Schaper Benz & Wise Investment Counsel Inc Regeneron Pharmaceuticals, Inc. Transaction History

Schaper Benz & Wise Investment Counsel Inc

  • $1.21 Billion
  • Q3 2024

A detailed history of Schaper Benz & Wise Investment Counsel Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Schaper Benz & Wise Investment Counsel Inc holds 18,114 shares of REGN stock, worth $13.4 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
18,114
Previous 17,925 1.05%
Holding current value
$13.4 Million
Previous $18.8 Million 1.08%
% of portfolio
1.57%
Previous 1.68%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$1024.09 - $1201.76 $193,553 - $227,132
189 Added 1.05%
18,114 $19 Million
Q2 2024

Aug 07, 2024
SELL
$883.2 - $1071.19 $75,072 - $91,051
-85 Reduced 0.47%
17,925 $18.8 Million
Q1 2024

Apr 29, 2024
BUY
$902.69 - $993.35 $78,534 - $86,421
87 Added 0.49%
18,010 $17.3 Million
Q4 2023

Feb 07, 2024
SELL
$775.18 - $881.7 $20,154 - $22,924
-26 Reduced 0.14%
17,923 $15.7 Million
Q3 2023

Oct 11, 2023
SELL
$692.45 - $844.37 $45,009 - $54,884
-65 Reduced 0.36%
17,949 $14.8 Million
Q2 2023

Jul 17, 2023
BUY
$700.03 - $830.35 $420,718 - $499,040
601 Added 3.45%
18,014 $12.9 Million
Q1 2023

May 01, 2023
SELL
$680.49 - $826.97 $123,168 - $149,681
-181 Reduced 1.03%
17,413 $14.3 Million
Q4 2022

Jan 25, 2023
SELL
$705.89 - $766.39 $823,773 - $894,377
-1,167 Reduced 6.22%
17,594 $0
Q3 2022

Oct 17, 2022
SELL
$573.97 - $724.32 $603,816 - $761,984
-1,052 Reduced 5.31%
18,761 $12.9 Million
Q2 2022

Aug 04, 2022
SELL
$548.35 - $738.84 $492,418 - $663,478
-898 Reduced 4.34%
19,813 $11.7 Million
Q1 2022

Apr 29, 2022
SELL
$595.12 - $698.43 $271,374 - $318,484
-456 Reduced 2.15%
20,711 $14.5 Million
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $165,217 - $203,974
304 Added 1.46%
21,167 $13.4 Million
Q3 2021

Oct 27, 2021
BUY
$574.03 - $680.96 $113,657 - $134,830
198 Added 0.96%
20,863 $12.6 Million
Q2 2021

Jul 29, 2021
BUY
$472.8 - $558.54 $143,258 - $169,237
303 Added 1.49%
20,665 $11.5 Million
Q1 2021

Apr 20, 2021
BUY
$446.73 - $548.2 $909,542 - $1.12 Million
2,036 Added 11.11%
20,362 $9.63 Million
Q4 2020

Feb 11, 2021
SELL
$478.3 - $607.98 $50,221 - $63,837
-105 Reduced 0.57%
18,326 $8.85 Million
Q3 2020

Nov 05, 2020
BUY
$544.75 - $658.21 $50,117 - $60,555
92 Added 0.5%
18,431 $10.3 Million
Q2 2020

Jul 30, 2020
SELL
$493.32 - $643.92 $202,261 - $264,007
-410 Reduced 2.19%
18,339 $11.4 Million
Q1 2020

May 04, 2020
BUY
$336.18 - $494.43 $32,273 - $47,465
96 Added 0.51%
18,749 $9.16 Million
Q4 2019

Jan 30, 2020
SELL
$274.13 - $376.51 $237,670 - $326,434
-867 Reduced 4.44%
18,653 $7 Million
Q3 2019

Nov 04, 2019
BUY
$273.46 - $318.39 $183,765 - $213,958
672 Added 3.57%
19,520 $5.42 Million
Q2 2019

Aug 05, 2019
BUY
$299.6 - $414.82 $605,791 - $838,766
2,022 Added 12.02%
18,848 $5.9 Million
Q1 2019

Apr 23, 2019
BUY
$372.08 - $439.57 $80,369 - $94,947
216 Added 1.3%
16,826 $6.91 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $58,768 - $70,532
175 Added 1.06%
16,610 $6.2 Million
Q3 2018

Oct 19, 2018
SELL
$351.14 - $408.51 $149,234 - $173,616
-425 Reduced 2.52%
16,435 $6.64 Million
Q2 2018

Aug 06, 2018
BUY
$284.6 - $344.99 $424,907 - $515,070
1,493 Added 9.72%
16,860 $5.82 Million
Q1 2018

Apr 30, 2018
BUY
$315.82 - $393.78 $748,177 - $932,864
2,369 Added 18.23%
15,367 $5.29 Million
Q4 2017

Jan 26, 2018
BUY
$358.63 - $469.95 $1 Million - $1.31 Million
2,794 Added 27.38%
12,998 $4.89 Million
Q3 2017

Nov 02, 2017
BUY
$431.38 - $504.0 $509,891 - $595,728
1,182 Added 13.1%
10,204 $4.56 Million
Q2 2017

Aug 07, 2017
BUY
N/A
9,022
9,022 $4.43 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Schaper Benz & Wise Investment Counsel Inc Portfolio

Follow Schaper Benz & Wise Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email